Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
15-04-20	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
15-01-30	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
14-12-05	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
14-11-20	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
14-11-18	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
14-10-28	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
14-07-31	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
14-07-25	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
14-07-17	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
14-06-24	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
14-06-19	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

15-03-04	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
15-01-28	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
14-12-06	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
14-12-01	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
14-07-29	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

14-07-17	Novartis : confirme l'objectif de croissance de ses ventes
14-07-17	Novartis : confirme l'objectif de croissance du C.A. annuel
14-06-19	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
14-04-22	S& 500 : Vague de fusions dans le domaine de la pharmacie
14-04-07	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-2.33%	-2.09%	+49.88%	+169.76%	1,060B
JOHNSON & JOHNSON	-0.82%	-2.30%	+63.79%	+62.56%	619B
ABBVIE INC.	-0.73%	-4.98%	+28.91%	+83.79%	438B
ROCHE HOLDING AG	+0.33%	-1.17%	+31.07%	+26.57%	333B
NOVARTIS AG	-0.02%	-2.85%	+29.15%	+46.14%	282B
ASTRAZENECA PLC	-3.89%	-11.22%	+22.81%	+25.23%	267B
NOVO NORDISK A/S	+0.66%	-1.42%	-26.59%	-37.67%	218B
AMGEN INC.	-0.06%	-2.88%	+23.07%	+61.02%	196B
GILEAD SCIENCES, INC.	-3.72%	-1.10%	+18.41%	+69.98%	161B
Average	-1.18%	-3.33%	+26.72%	+56.38%	397.1B
Weighted average by Cap.	-1.31%	-3.10%	+36.75%	+83.66%

Employees

Sector